<DOC>
	<DOCNO>NCT02284932</DOCNO>
	<brief_summary>Limb muscle dysfunction , characterize atrophy weakness , amongst troublesome systemic consequence chronic obstructive pulmonary disease ( COPD ) lead poor functional status premature mortality . One prevail hypothesis stipulates deterioration muscle structure function COPD result spillover inflammatory mediator lung systemic circulation muscle .</brief_summary>
	<brief_title>Muscle Atrophy In Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>The investigator objective investigate impact COPD key signal pathway involve muscle atrophy . Moderate severe COPD patient ( FEV1 60 % predict ) healthy control recruit . All investigator patient undergo thorough baseline assessment pulmonary capacity , muscle force body composition . Blood sample biopsy quadriceps do . Key proteins signal intramuscular pathway involve protein synthesis degradation measure quadriceps .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<criteria>male COPD FEV1 60 % predict nonsmoker 55 75 year old inflammatory disease ( HIV , cancer , renal cardiac deficiency ) hormonal dysregulation inferior limb pathology neuromuscular pathology history tobacco alcool abuse oxygen dependent recent exacerbation ( 2 month ) symptom COPD</criteria>
	<gender>Male</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>atrophy</keyword>
	<keyword>muscle</keyword>
</DOC>